As per the Future Market Insights’ latest industry analysis, the global Ligament Augmentation Market is set to grow from US$ 41.0 Mn in 2021 to US$ 76.3 Mn by 2032, expanding at a CAGR of 5.8% over the forecast period. One of the body’s strongest ligaments, the anterior cruciate ligament (ACL) in the knee, is frequently the target of traumatic injuries. Unfortunately, it …
Category Archives: Healthcare Trends
Cosmetology Market | GC Aesthetics, Mentor Worldwide LLC, Sientra Inc., Zimmer Holdings Inc. | By 2032
The estimated value of the worldwide Cosmetology Market in 2022 is US$108.3 billion. By 2032, the market is expected to have grown by 10.9% CAGR from 2022 to 2032, approaching US$ 336.53 billion. Cosmetology is the study of beauty, treatments and its applications. There are various branches of specialty in the cosmetology market, i.e. hairstyling, skin …
Handheld Ultrasound Scanners Market | GE Healthcare, Fujifilm SonoSite, Inc., Clarius Mobile Health, Signostics Limited | By 2032
Between 2022 and 2032, the global Handheld Ultrasound Scanners Market is expected to grow at a 9.1% CAGR, reaching US$ 472.1 Million by the end of 2022. By 2032, sales are expected to surpass a valuation of US$ 1.1 billion. The wired modality is the market leader, with an estimated 83.6% market share in 2021. …
Keloid Treatment Market | Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc. By 2032
The global Keloid Treatment Market size reached US$ 3.6 Bn in 2021 and is expected to enjoy a valuation of US$ 3.7 Bn by the end of 2022. Furthermore, with rising prevalence of keloid across the world, the overall demand for keloid treatment is set to grow at 3.2% CAGR between 2022 and 2032, totalling a valuation of ~US$ 5.1 Bn by 2032. Global Keloid Treatment Market: …
Breathing Circuits Market | C. R. Bard Inc., Ambu A/S, Armstrong Medical Industries, Inc., Altera Corp. | By 2032
By the end of 2022, the market for Breathing Circuits Market is anticipated to be worth US$ 1,163.32 Mn and grow at a CAGR of 4.2% from 2022 to 2032. By the end of 2032, the market is projected to be worth US$ 1,758.18 million. In 2021, open breathing circuits dominated the market with a 43.6% market …
Lab Automation Market | Abbott Laboratories, Agilent Technologies, Perkin Elmer Inc | By 2033
The Lab Automation Market is anticipated to reach US$ 2.1 billion in 2023. The lab automation market is anticipated to expand at a CAGR of 10.1% during the forecast period, reaching US$ 5.5 billion by 2033 due to the rising usage of lab automation across numerous end-use verticals. Research and Innovations Aid Market Growth Pharmaceutical …
Endoscope Reprocessing Market | Medivators Inc., Olympus Corp., STERIS Plc., Getinge Group | By 2032
The Endoscope Reprocessing Device Market is expected to reach US$ 3.1 Bn by the end of 2032, with sales revenue likely to register a 7.8% CAGR from 2022-2032. This growth is expected to be primarily driven by growing geriatric population, increasing number of Endoscope surgeries and development of automated endoscope reprocessor and techniques. According to …
Flow Cytometry Market | Miltenyi Biotech, Luminex Corp., Merck KGaA, bioMérieux SA | By 2032
The global Flow Cytometry Market is expected to enjoy a lucrative growth opportunity with an expanded CAGR of 7.4% from 2022 to 2032. The global market is anticipated to reach a valuation of US$ 5.6 Billion by the end of the year 2022 and reach an estimation of nearly US$ 11.4 Billion by the year 2032. …
Antisense Oligonucleotides Market | Bio-Path Holdings, Inc., Gene Signal International SA, GlaxoSmithKline plc, Geron Corporation | By 2032
The global Antisense Oligonucleotides Market is expected to generate US$ 5,659.2 million in revenue by 2032, up from US$ 1,921.6 million in 2022, with a CAGR of 10.3% over the forecast period. Antisense Oligonucleotides market players – Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited among others represent the global Antisense Oligonucleotides market. The market study depicts an extensive …
Congenital Adrenal Hyperplasia Treatment Market is expected to grow with an 8.1% CAGR during 2023 to 2033
During the forecast period 2023 to 2033, the Congenital Adrenal Hyperplasia treatment market is expected to grow at a value of 8.1% CAGR, according to Future Market Insights. By the year 2033, the global market for Congenital Adrenal Hyperplasia treatment is expected to rise up to a market valuation of US$ 892 Million. Growth of …